New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
Monoclonal antibody cliramitug shows sustained benefit in cardiac amyloidosis over 29 months
Long-term follow-up of the NI006-101 trial shows that cliramitug, a monoclonal antibody targeting misfolded transthyretin, sustains clinical benefit in cardiac…
Editor's Top Picks
AI-Assisted Clinical Decision Support Shows No Benefit Over Standard Care in Kenyan Primary Care Study
A pragmatic cluster-randomized trial in Kenya found that ChatGPT-4o-assisted clinical decision support did not significantly reduce treatment failure rates in…
Submit Your Paper →
More form New Studies
Stem Cell Therapy Shows Breakthrough Potential for Diabetes Treatment
Researchers are harnessing embryonic stem cells' unique ability to transform into any cell type to…
Community-based ultrasound screening cuts infant hip dysplasia late diagnosis by 85%
University of Tokyo researchers demonstrate that community-based ultrasound screening identifies hip dysplasia in 8.7% of…
Brain Signal After Exercise May Determine Fitness Gains, Study Finds
New research identifies SF1 neurons in the brain that activate for one hour after exercise…
Largest Genetic Study Reveals Any Level of Alcohol Consumption Increases Dementia Risk
Genetic analysis of 2.4 million participants reveals any level of alcohol consumption increases dementia risk…
Disrupted Circadian Rhythms Trigger Gut Barrier Breakdown and Digestive Dysfunction
New research reveals that disrupted circadian rhythms fundamentally alter gut function, weakening protective barriers and…